Delivery Order SPE2DB22D2211-SPE2DB23FPAL4

Award Date 8/24/23
Potential Completion Date 8/25/23
Potential Value $4.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $1,954.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/20 ml vials of ropivacaine hydrochloride injection 1%. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order is for a single day of delivery on July 18, 2023 to fulfill DLA requirements, with no subcontractors involved. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this...
The Defense Logistics Agency awarded a $7,619 delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The single delivery order is for 200 ml of the specified product and will be fulfilled by August 8, 2023 out of Amerisourcebergen's facility in Conshohocken, Pennsylvania. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor for the DOD and...
The Defense Logistics Agency awarded a $843.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/100 ml vials of ropivacaine hydrochloride injection. As the prime contractor, Amerisourcebergen will deliver 100 ml vials of the anesthetic to its facility in Conshohocken, Pennsylvania within the period of performance from August 23 to August 24, 2023. The order was placed under an existing DLA pharmaceuticals contract vehicle to support the agency's medical supply...
The Defense Logistics Agency awarded a $6,486.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride, a long-acting amide local anesthetic. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between September 4-5, 2023. The order was placed under an existing DLA pharmaceuticals contract vehicle to supply anesthetics and other drug products in support of U.S....
The Defense Logistics Agency awarded a $2,340 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride, a sterile injectable anesthetic. The contract calls for Amerisourcebergen to deliver 200 ml of the anesthetic from its facility in Conshohocken, Pennsylvania to an unknown customer by June 26, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain...
The Defense Logistics Agency awarded a $2,280.05 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/100 ml vials of ropivacaine hydrochloride injection 0.2%. Performance will take place in Conshohocken, Pennsylvania over one day in late August 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order from its corporate office division. The delivery order was issued under an existing DLA contract...
The Defense Logistics Agency awarded a $3,509 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The prime contractor will deliver the analgesic drug from its Conshohocken, Pennsylvania facility to support DLA requirements. No major subcontractors or set aside designations were indicated. This award draws from DLA's indefinite delivery vehicle for pharmaceuticals to supply military treatment facilities and...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $5,649 to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania by August 29, 2023 in support of the Defense Logistics Agency's medical supply chain requirements. No set aside...
The Defense Logistics Agency awarded a $432 delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility by September 15, 2023 in accordance with firm fixed price terms. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified. The...
The Defense Logistics Agency Troop Support Medical awarded a $451.50 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 150 mg/30 ml vials of ropivacaine hydrochloride injection 0.5%. As the prime contractor, Amerisourcebergen Drug will deliver the local anesthetic to its place of performance in Conshohocken, Pennsylvania within the one day period of August 29-30, 2023. The delivery order was placed against an existing DLA medical supply vehicle and...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB23FPAL4
    Delivery Order

The Defense Logistics Agency awarded a $4,324.60 firm fixed price delivery order to Amerisourcebergen Drug Corp for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements. The single delivery is scheduled to take place between August 24-25, 2023. No subcontractors or set aside designations were indicated. This order is likely in support of DLA's stockpile of medical supplies to equip U.S. military treatment facilities and contingency operations worldwide.

Generated 12/17/23, 1:58 AM